Cited by 139Computational Drug Discovery MethodsMachine Learning in Materials ScienceCholinesterase and Neurodegenerative Diseases

Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions

Open access
Myint, Kyaw-Zeyar, Wang, Lirong, Tong, Qin, Xie, Xiang-Qun·2012·Molecular Pharmaceutics

Abstract

In this manuscript, we have reported a novel 2D fingerprint-based artificial neural network QSAR (FANN-QSAR) method in order to effectively predict biological activities of structurally diverse chemical ligands. Three different types of fingerprints, namely, ECFP6, FP2 and MACCS, were used in FANN-QSAR algorithm development, and FANN-QSAR models were compared to known 3D and 2D QSAR methods using five data sets previously reported. In addition, the derived models were used to predict GPCR cannabinoid ligand binding affinities using our manually curated cannabinoid ligand database containing 1699 structurally diverse compounds with reported cannabinoid receptor subtype CB(2) activities. To demonstrate its useful applications, the established FANN-QSAR algorithm was used as a virtual screening tool to search a large NCI compound database for lead cannabinoid compounds, and we have discovered several compounds with good CB(2) binding affinities ranging from 6.70 nM to 3.75 μM. To the best of our knowledge, this is the first report for a fingerprint-based neural network approach validated with a successful virtual screening application in identifying lead compounds. The studies proved that the FANN-QSAR method is a useful approach to predict bioactivities or properties of ligands and to find novel lead compounds for drug discovery research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/mp300237z

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Myint, K.-Z., Wang, L., Tong, Q., & Xie, X.-Q.
Affiliations
University of Pittsburgh (US)
Corresponding author
Xie, Xiang-Qun
Venue
Molecular Pharmaceutics
Published
2012-08-31
Volume
9
Issue
10
Pages
2912-2923
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W2081709350
Cited by
139
References
64
Citations by year
2026: 5 · 2025: 17 · 2024: 8 · 2023: 16 · 2022: 12 · 2021: 9 · 2020: 19 · 2019: 11 · 2018: 14 · 2017: 4 · 2016: 13 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 2
FWCI
4.12
Type
journal article
Language
en
Open access
Locations
  • Molecular Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute
  • University of Pittsburgh
  • Carnegie Mellon University
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R21HL109654)
  • National Institute on Drug Abuse (R01DA025612)
  • National Institute of General Medical Sciences (P50GM067082)
  • National Institute of Biomedical Imaging and Bioengineering (T32EB009403)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
molecular fingerprints, artificial neural networks, CB2 receptor, cannabinoid ligands, virtual screening, MACCS, lead compound identification
MeSH terms
Dermatoglyphics, Ligands, Models, Chemical, Databases, Factual, Neural Networks, Computer, Quantitative Structure-Activity Relationship, Receptor, Cannabinoid, CB2, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review